scispace - formally typeset
N

N.H. Kulkarni

Researcher at Eli Lilly and Company

Publications -  13
Citations -  845

N.H. Kulkarni is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Parathyroid hormone & Ovariectomized rat. The author has an hindex of 10, co-authored 13 publications receiving 807 citations.

Papers
More filters
Journal ArticleDOI

Effects of parathyroid hormone on Wnt signaling pathway in bone.

TL;DR: The findings suggest that the effect of PTH on the canonical Wnt signaling pathway occurs at least in part via the cAMP‐PKA pathway through the differential regulation of the receptor complex proteins (FZD‐1/LRP5 or LRP6) and the antagonist (Dkk‐1).
Journal ArticleDOI

Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes

TL;DR: Co-treatment with sCT can blunt the anabolic effect of PTH and this may involve direct stimulation of sclerostin production by osteocytes, which directly implicate calcitonin as a negative regulator of bone formation through a previously unsuspected mechanism.
Journal ArticleDOI

Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray

TL;DR: The broad profiling of the gene and pathway changes that occur in vivo following treatment of intermittent versus continuous PTH is detailed for the first time and the in vivo regulation of BMP3 and multiple neuronal genes by PTH treatment is revealed.